These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32086240)

  • 1. iNOS Regulates the Therapeutic Response of Pancreatic Cancer Cells to Radiotherapy.
    Pereira PMR; Edwards KJ; Mandleywala K; Carter LM; Escorcia FE; Campesato LF; Cornejo M; Abma L; Mohsen AA; Iacobuzio-Donahue CA; Merghoub T; Lewis JS
    Cancer Res; 2020 Apr; 80(8):1681-1692. PubMed ID: 32086240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPR68, a proton-sensing GPCR, mediates interaction of cancer-associated fibroblasts and cancer cells.
    Wiley SZ; Sriram K; Liang W; Chang SE; French R; McCann T; Sicklick J; Nishihara H; Lowy AM; Insel PA
    FASEB J; 2018 Mar; 32(3):1170-1183. PubMed ID: 29092903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-Induced Inflammatory Gene Signature and Protumorigenic Phenotype in Pancreatic CAFs via Stress-Associated MAPK.
    Toste PA; Nguyen AH; Kadera BE; Duong M; Wu N; Gawlas I; Tran LM; Bikhchandani M; Li L; Patel SG; Dawson DW; Donahue TR
    Mol Cancer Res; 2016 May; 14(5):437-47. PubMed ID: 26979711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta.
    Müerköster S; Wegehenkel K; Arlt A; Witt M; Sipos B; Kruse ML; Sebens T; Klöppel G; Kalthoff H; Fölsch UR; Schäfer H
    Cancer Res; 2004 Feb; 64(4):1331-7. PubMed ID: 14973050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR2 signaling promotes secretory cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.
    Awaji M; Saxena S; Wu L; Prajapati DR; Purohit A; Varney ML; Kumar S; Rachagani S; Ly QP; Jain M; Batra SK; Singh RK
    FASEB J; 2020 Jul; 34(7):9405-9418. PubMed ID: 32453916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment.
    Garcia Garcia CJ; Huang Y; Fuentes NR; Turner MC; Monberg ME; Lin D; Nguyen ND; Fujimoto TN; Zhao J; Lee JJ; Bernard V; Yu M; Delahoussaye AM; Jimenez Sacarello I; Caggiano EG; Phan JL; Deorukhkar A; Molkentine JM; Saur D; Maitra A; Taniguchi CM
    Gastroenterology; 2022 Jun; 162(7):2018-2031. PubMed ID: 35216965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrin α11 in pancreatic stellate cells regulates tumor stroma interaction in pancreatic cancer.
    Schnittert J; Bansal R; Mardhian DF; van Baarlen J; Östman A; Prakash J
    FASEB J; 2019 May; 33(5):6609-6621. PubMed ID: 30808244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors.
    Djurec M; Graña O; Lee A; Troulé K; Espinet E; Cabras L; Navas C; Blasco MT; Martín-Díaz L; Burdiel M; Li J; Liu Z; Vallespinós M; Sanchez-Bueno F; Sprick MR; Trumpp A; Sainz B; Al-Shahrour F; Rabadan R; Guerra C; Barbacid M
    Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1147-E1156. PubMed ID: 29351990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-associated fibroblasts reprogram cysteine metabolism to increase tumor resistance to ferroptosis in pancreatic cancer.
    Zhu Y; Fang S; Fan B; Xu K; Xu L; Wang L; Zhu L; Chen C; Wu R; Ni J; Wang J
    Theranostics; 2024; 14(4):1683-1700. PubMed ID: 38389839
    [No Abstract]   [Full Text] [Related]  

  • 10. Desmoplastic Crosstalk in Pancreatic Ductal Adenocarcinoma Is Reflected by Different Responses of Panc-1, MIAPaCa-2, PaTu-8902, and CAPAN-2 Cell Lines to Cancer-associated/Normal Fibroblasts.
    Novák Š; Kolář M; Szabó A; Vernerová Z; Lacina L; Strnad H; Šáchová J; Hradilová M; Havránek J; Španko M; Čoma M; Urban L; Kaňuchová M; Melegová N; Gürlich R; Dvořák J; Smetana K; Gál P; Szabo P
    Cancer Genomics Proteomics; 2021; 18(3):221-243. PubMed ID: 33893076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micro-RNA-21 Regulates Cancer-Associated Fibroblast-Mediated Drug Resistance in Pancreatic Cancer.
    Zhang L; Yao J; Li W; Zhang C
    Oncol Res; 2018 Jul; 26(6):827-835. PubMed ID: 28477403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.
    Zhao W; Ajani JA; Sushovan G; Ochi N; Hwang R; Hafley M; Johnson RL; Bresalier RS; Logsdon CD; Zhang Z; Song S
    Gastroenterology; 2018 Apr; 154(5):1524-1537.e6. PubMed ID: 29274868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential.
    Knudsen ES; Balaji U; Freinkman E; McCue P; Witkiewicz AK
    Oncotarget; 2016 Nov; 7(48):78396-78411. PubMed ID: 27623078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts.
    Elyada E; Bolisetty M; Laise P; Flynn WF; Courtois ET; Burkhart RA; Teinor JA; Belleau P; Biffi G; Lucito MS; Sivajothi S; Armstrong TD; Engle DD; Yu KH; Hao Y; Wolfgang CL; Park Y; Preall J; Jaffee EM; Califano A; Robson P; Tuveson DA
    Cancer Discov; 2019 Aug; 9(8):1102-1123. PubMed ID: 31197017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor-κB activation.
    Ju HQ; Li H; Tian T; Lu YX; Bai L; Chen LZ; Sheng H; Mo HY; Zeng JB; Deng W; Chiao PJ; Xu RH
    J Pineal Res; 2016 Jan; 60(1):27-38. PubMed ID: 26445000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CAFs-Associated Genes (CAFGs) in Pancreatic Ductal Adenocarcinoma (PDAC) and Novel Therapeutic Strategy.
    Yamashita K; Kumamoto Y
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer.
    Belle JI; Sen D; Baer JM; Liu X; Lander VE; Ye J; Sells BE; Knolhoff BL; Faiz A; Kang LI; Qian G; Fields RC; Ding L; Kim H; Provenzano PP; Stewart SA; DeNardo DG
    Cancer Discov; 2024 Jul; 14(7):1324-1355. PubMed ID: 38683144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities.
    Qin Q; Yu R; Eriksson JE; Tsai HI; Zhu H
    Cancer Lett; 2024 Jun; 591():216859. PubMed ID: 38615928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
    Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
    Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Aggressive Fibroblasts to Enhance the Treatment of Pancreatic Cancer.
    Yu Y; Schuck K; Friess H; Kong B
    Expert Opin Ther Targets; 2021 Jan; 25(1):5-13. PubMed ID: 33246383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.